8 years of revenue, profit, cash flow and balance-sheet history through FY2025,
from SEC filings — with a computed, factual read of the trend.
Updated Overview →
Growth & profitability
Revenue has grown 0.6% per year over the past 5 years.
Operating margin has expanded, at 3.0% in the latest year.
Financial health
Total debt ($4.6B) exceeds cash ($17M); net debt is $4.6B.
Total debt has grown in line with revenue (-1.9% vs 0.6% per year).
Operating income covered interest expense 0.1× in the latest year.
Total debt is 160× EBITDA.
The company is unprofitable; at its current free-cash-flow burn it has roughly 1.4 years of cash runway.
Revenue & net income
RevenueNet income
Margins (gross / operating / net)
GrossOperatingNet
Free cash flow (CFO − capex)
Free cash flow
Cash vs total debt
CashTotal debt
Cash flow: operating / investing / financing
OperatingInvestingFinancing
Key annual figures
FY
Revenue
Net income
Gross M
Op M
FCF
Total debt
Cash
2025
$965M
-$284M
0.0%
3.0%
-$12M
$4.6B
$17M
2024
$931M
-$1.6B
0.0%
-149.4%
-$11M
$4.6B
$17M
2023
$962M
-$92M
0.0%
16.8%
$63M
$4.6B
$72M
2022
$1.1B
-$573M
0.0%
-33.6%
$283M
$4.8B
$334M
2021
$1.1B
$102M
0.0%
34.5%
$320M
$5.0B
$185M
2020
$938M
-$521M
0.0%
-14.1%
$307M
—
$127M
2019
$983M
$10M
0.0%
37.5%
$218M
—
$22M
2018
$1.0B
$36M
0.0%
41.1%
$229M
—
—
Revenue & net income
RevenueNet income
Margins (gross / operating / net)
GrossOperatingNet
Free cash flow (CFO − capex, quarterly)
Free cash flow
Cash vs total debt
CashTotal debt
Cash flow: operating / investing / financing
OperatingInvestingFinancing
Key quarterly figures
Quarter
Revenue
Net income
Gross M
Op M
FCF
Total debt
Cash
Mar '26
$245M
-$74M
0.0%
2.7%
-$93M
$4.6B
$21M
Dec '25
$247M
-$81M
0.0%
-3.1%
$36M
$4.6B
$17M
Sep '25
$246M
-$70M
0.0%
4.1%
-$16M
$4.6B
$39M
Jun '25
$242M
-$63M
0.0%
6.9%
$37M
$4.6B
$56M
Mar '25
$231M
-$71M
0.0%
4.2%
-$69M
$4.6B
$23M
Dec '24
$232M
-$138M
0.0%
-17.8%
-$64M
$4.6B
$17M
Sep '24
$230M
-$391M
0.0%
-146.7%
$41M
—
$87M
Jun '24
$233M
-$577M
0.0%
-224.4%
-$7M
—
$49M
Mar '24
$235M
-$540M
0.0%
-207.4%
$19M
—
$59M
Dec '23
$244M
-$31M
0.0%
16.7%
-$4M
$4.6B
$72M
Sep '23
$243M
-$24M
0.0%
16.3%
$50M
—
$101M
Jun '23
$238M
-$36M
0.0%
14.6%
-$24M
—
$90M
Mar '23
$237M
$209000
0.0%
19.8%
$41M
—
$266M
Dec '22
$241M
-$650M
0.0%
-254.5%
$2M
$4.8B
$334M
Sep '22
$250M
$20M
0.0%
14.5%
$88M
—
$439M
Jun '22
$290M
$14M
0.0%
33.7%
$22M
—
$354M
Mar '22
$298M
$44M
0.0%
39.1%
$170M
—
$351M
Dec '21
$298M
$25M
0.0%
36.7%
$6M
$5.0B
$185M
Sep '21
$288M
$78M
0.0%
36.2%
$147M
—
$225M
Jun '21
$276M
-$47M
0.0%
32.5%
$15M
—
$148M
Valuation over time
How the market has priced CTEV against its own fundamentals since 2025-02 —
each month-end's share price set against the most recent annual filing, so the multiple moves
as price runs ahead of (or behind) earnings. Split-adjusted.
The price-to-sales ratio has risen from 0.4× (Feb '25) to 0.6× (Jun '26).
Price / sales (P/S)
P/S
Frequently asked questions
Is CTEV growing its revenue and profit?
Over the past 5 years, Claritev Corp's revenue has grown 0.6% per year. These are computed facts, not advice.
How much debt does CTEV have?
As of FY2025, Claritev Corp reported $4.6B of total debt against $17M of cash; operating income covered interest expense 0.1×.
What is CTEV's profit margin?
In FY2025, gross margin was —, operating margin 3.0%, and net margin -29.4%.
Where does this data come from?
All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.
Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), corporate-action-adjusted ·
growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price
against the latest annual filing. Informational only — not investment advice.